Boston Scientific (BSX) Tops Q3 EPS by 4c; beats on guidance
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $46.95 --0%
Revenue Growth %: +3.7%
Financial Fact:
Royalty expense: 20M
Today's EPS Names:
PMCB, CULP, HURC, More
Revenue Growth %: +3.7%
Financial Fact:
Royalty expense: 20M
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.75, $0.04 better than the analyst estimate of $0.71. Revenue for the quarter came in at $5.07 billion versus the consensus estimate of $4.97 billion.
GUIDANCE:
Boston Scientific sees Q4 2025 EPS of $0.77-$0.79, versus the consensus of $0.76.
Boston Scientific sees FY2025 EPS of $3.02-$3.04, versus the consensus of $2.98.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Sodexo (SW:FP) (SDXAY) PT Raised to EUR58.60 at Bernstein SocGen Group
- Morgan Stanley Previews Navan Inc (NAVN) Earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
